Biospace: Errant Escalates Complaints to Lawsuit Over bluebird bio’s Gene Therapy

Oct 26, 2021 | News

The ongoing battle between bluebird bio and tiny Errant Gene Therapeutics has escalated into a full-blown patent lawsuit, with Chicago-based Errant alleging that bluebird’s LentiGlobin and Zynteglo gene therapies infringe on patents for recombinant vectors they own.

View the rest of the article here

View the PDF

Contact us

Call Us

+1 (312) 441-1800

Our Locations

San Rocco Therapeutics
308 E. Emily St.
Tampa, FL 33603


Get in touch